TY - CHAP M1 - Book, Section TI - Heart Disease in Chronic Kidney Disease A1 - Hooker, Jared A1 - Baber, Omar A1 - Baber, Usman A2 - Fuster, Valentin A2 - Narula, Jagat A2 - Vaishnava, Prashant A2 - Leon, Martin B. A2 - Callans, David J. A2 - Rumsfeld, John S. A2 - Poppas, Athena PY - 2022 T2 - Fuster and Hurst's The Heart, 15e AB - Content UpdateEMPA-KIDNEY: Empagliflozin and Chronic Kidney DiseaseThe EMPA-KIDNEY trial was an international, randomized, parallel-group, double-blind, placebo-controlled, clinical trial designed to assess the effect of 10 mg once daily empagliflozin treatment on the progression of chronic kidney disease (CKD) and cardiovascular disease and to examine the safety profile of the drug in a wide range of patients with CKD. Read More SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesscardiology.mhmedical.com/content.aspx?aid=1202453209 ER -